Group 1 - The company Sunflower expects a net profit loss attributable to shareholders of 3.8 million to 5.68 million yuan for 2025, marking a shift from profit to loss year-on-year [1] - The primary reasons for the performance change include a decline in market demand and intensified industry competition, leading to a decrease in revenue from the company's formulation drug business [1] - The raw material drug business also experienced a slight decline in sales due to a reduction in some overseas orders, contributing to a decrease in overall operating revenue and gross profit year-on-year [1] Group 2 - The company has made provisions for asset impairment based on a cautious principle, resulting in a significant increase in asset impairment losses compared to the same period last year [1]
向日葵:预计2025年度净利润亏损380万元~568万元